INTASYL

Serial Number 98073145
731

Registration Progress

Application Filed
Jul 6, 2023
Under Examination
Jun 18, 2024
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Dec 18, 2025 135 days

Trademark Image

INTASYL

Basic Information

Serial Number
98073145
Filing Date
July 6, 2023
Published for Opposition
April 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
May 15, 2025
Application
Pending
Classes
005

Rights Holder

Phio Pharmaceuticals Corp.

03
Address
257 Simarano Drive, Suite 101
Marlborough, MA 01752

Ownership History

Phio Pharmaceuticals Corp.

Original Applicant
03
Marlborough, MA

Phio Pharmaceuticals Corp.

Owner at Publication
03
Marlborough, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
135 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 18, 2025
Extension Available
Until June 18, 2025

Application History

17 events
Date Code Type Description Documents
May 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 15, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
May 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 15, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 14, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 18, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 6, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, hematology and in tissue and organ regeneration, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, liver diseases and disorders, antifungal, anti-infective, antiviral preparations and antibiotics

Classification

International Classes
005